4/A//SEC Filing
Hutson Nancy J 4/A
Accession 0001169245-22-000067
CIK 0001169245other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:47 PM ET
Size
6.1 KB
Accession
0001169245-22-000067
Insider Transaction Report
Form 4/AAmended
Hutson Nancy J
Director
Transactions
- Purchase
Common Stock
2021-08-18$3.08/sh+3,000$9,240→ 4,000 total(indirect: Held in an individual retirement account for the benefit of the Reporting Person)
Holdings
- 33,760
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]Amended to report direct share ownership.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001379222
Filing Metadata
- Form type
- 4/A
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:47 PM ET
- Size
- 6.1 KB